Elanco Animal Health Inc (FRA:5EA)
€ 15.518 -0.038 (-0.24%) Market Cap: 7.82 Bil Enterprise Value: 12.80 Bil PE Ratio: 0 PB Ratio: 1.40 GF Score: 66/100

Elanco Animal Health Inc at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 12:45PM GMT
Release Date Price: €25.55 (+3.07%)
David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

Thanks very much for joining us for the Elanco session. My name is Dave Risinger. I cover major and specialty pharmaceuticals at Morgan Stanley. I need to refer you to the disclaimers at www.morganstanley.com/researchdisclosures.

Just to give you a quick intro on Jeff Simmons who is the company's Chairman and CEO. As head of Elanco Animal Health for the past decade, Jeff has directed the company's transformation from primarily a U.S. feed additive company to a premier global player with a balanced and diversified business. And obviously, the transaction that the company has announced with Bayer further diversifies them, dramatically boosts their presence both in Companion Animals and also geographically in emerging markets. And so we're very much pleased to have Jeff with us today.

Jeff, I'd thought I'd turn it over to you to kick off with some comments, and then we'll take it

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot